T

Transchem Limited

TRANSCHEM
Market snapshot · 2026-08-10 21:11 UTC

305.45

₹-5.75 (-1.85%)

MARKET CAP

₹373.87 Cr

STOCK P/E

86.8x

52W HIGH

₹377.65

52W LOW

₹38.31

BOOK VALUE

₹68.28

EPS

₹3.52

ROE

5.27%

SECTOR

Health Care

DEBT/EQUITY

VOLUME

1,802

P/B RATIO

4.47x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹356.15₹277.01₹197.87₹118.73₹39.59VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Forecast

Analyst targets, estimate history, and probabilistic forward ranges for TRANSCHEM.

Coverage check

Price Forecast

Current
₹305.45
High Target
Median Target
Low Target
Now₹305.45Aug '25Now12M Target
Price history (1Y)
Analyst target range

Revenue Forecast

₹ Cr
Mar '25Current₹2.0
Dec '24: ₹0.0 · Mar '25: ₹2.0
Dec '24Mar '250.02.0
PastCurrent

EPS Forecast

₹ / share
Mar '26Current₹1.71
Sep 2026 ETrend estimate range
High₹2.87Base₹2.57Low₹2.26
Mar '25: ₹0.60 · Jun '25: ₹0.81 · Dec '25: ₹0.43 · Mar '26: ₹1.71 · Sep '26: ₹2.57 · Dec '26: ₹0.65
Mar '25Jun '25Dec '25Mar '26Sep '26 EDec '26 E0.600.810.431.712.570.65
PastCurrentTrend estimate: Low / Base / High
Analyst price target unavailable from FMP/yfinance. Analyst recommendation consensus unavailable from FMP/yfinance. Analyst pillar unavailable from FMP/yfinance.
Market Intelligence

Multi-factor synthesis of 5 key dimensions

Overall Outlook
Cautious
24%
Analyst Consensus
Unavailable

Analyst coverage unavailable

Mean upsideNot available

Fundamentals

Weakening

Fundamentals institutional score is 26 using EVA spread proxy -6.7%; accruals ratio 1.957; growth durability 66.7.

Valuation

Premium valuation

Valuation institutional score is 3 using relative multiple z-scores where peer dispersion is available.

Analyst Consensus

Unavailable

No usable analyst target or recommendation data was available.

Technical Structure

Unavailable

This data source has not been supplied for the decision payload.

Market Sentiment

Neutral backdrop

Recent news flow is balanced or not decisive enough to tilt the tape. Based on 2 recent ticker-linked news items.

Signal Summary

Market intelligence remains Cautious. Available evidence provides partial support, while fundamentals and valuation remain considerations.

Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.

Fundamentals WeakeningValuation Premium valuationMarket Sentiment Neutral backdrop

Key Data Points

Mean Target PriceUnavailable
Mean UpsideNot available
Technical ScoreUnavailable
Fundamental Score26%
Data CoverageMedium

Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.

Valuation Metrics

Trading 650.5% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.88). Confidence: 50%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/B
Strongly Overvalued

5Y Average

2.19

Current

4.47

Overvalued

2.85

Undervalued

0.77

P/E
Strongly Overvalued

5Y Average

17.67

Current

88.41

Overvalued

19.60

Undervalued

10.24

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrMar 2026

Latest net profit

₹2.00 CrMar 2026

Latest EPS

₹1.71Mar 2026

Free cash flow

₹-2.00 CrMar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-22.0%-21.0%-20.0%-19.0%-18.0%0.00 Cr0.50 Cr1.00 Cr1.50 Cr2.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr0.50 Cr1.00 Cr1.50 Cr2.00 Cr₹0₹0₹1₹1₹2
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeOtheradjustmentsProfitbefore taxTax & otherNet Profit-1.00 Cr0.00 Cr1.00 Cr2.00 Cr3.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Debt free
Mar 2025Mar 2026-30 Cr0.00 Cr30 Cr60 Cr90 Cr
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹0 Cr

-100.0%

Net Profit

₹2 Cr

+50.7%

EBITDA

₹-1 Cr

-288.1%

EPS

₹1.71

+51.3%
MetricDec 2024Mar 2025Jun 2025Dec 2025Mar 2026
Sales02000
Expenses13011
Operating Profit-0-0-0-1-1
OPM %-164.61%-19.94%
Other Income22224
Interest0
Depreciation00000
Profit before tax21112
Tax %25.08%32.31%26.48%43.57%12.32%
Net Profit11112
EPS in Rs1.130.600.810.431.71

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters56.45%56.45%56.45%56.45%56.45%
DII0.04%0.04%0.04%0.04%0.04%
Public24.69%24.76%23.38%21.79%20.84%
Others18.82%18.75%20.13%21.72%22.67%
Mar 2026
Promoters
DII
Public
Others